HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population.

Rong, Lulu; Wang, Bingzhi; Guo, Lei; Liu, Xiuyun; Wang, Bingning; Ying, Jianming; Xue, Liyan; Lu, Ning

Rong, Lulu; Wang, Bingzhi; Guo, Lei; Liu, Xiuyun; Wang, Bingning; Ying, Jianming; Xue, Liyan; Lu, Ning.

Afiliación

Rong L; Department of Pathology and Resident Training Base, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Wang B; Department of Pathology and Resident Training Base, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Guo L; Department of Pathology and Resident Training Base, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Liu X; Department of Pathology and Resident Training Base, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Wang B; Department of Pathology and Resident Training Base, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Ying J; Department of Pathology and Resident Training Base, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Xue L; Department of Pathology and Resident Training Base, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. xuely@cicams.ac.cn.
Lu N; Center for Cancer Precision Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. xuely@cicams.ac.cn.

Diagn Pathol ; 15(1): 27, 2020 Mar 24.

Article en En | MEDLINE | ID: mdl-32209107

Asunto(s)

Biomarcadores de Tumor/análisis; Neoplasias Esofágicas/patología; Carcinoma de Células Escamosas de Esófago/patología; Receptor ErbB-2/biosíntesis; Adulto; Anciano; Anciano de 80 o más Años; Pueblo Asiatico; Neoplasias Esofágicas/genética; Neoplasias Esofágicas/metabolismo; Carcinoma de Células Escamosas de Esófago/genética; Carcinoma de Células Escamosas de Esófago/metabolismo; Femenino; Amplificación de Genes; Humanos; Inmunohistoquímica/métodos; Hibridación Fluorescente in Situ/métodos; Masculino; Persona de Mediana Edad; Receptor ErbB-2/genética; Reproducibilidad de los Resultados; Estudios Retrospectivos

Palabras clave

Clinicopathological characteristics; Dual-color in situ hybridization; Esophageal squamous cell carcinoma; HER2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Biomarcadores de Tumor / Receptor ErbB-2 / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Diagn Pathol Asunto de la revista: PATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google